$QNCX
Quince Therapeutics, Inc.

2021 Q3 Form 10-Q Financial Statement

#000095017021001015 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.640M $7.060M $4.190M
YoY Change 54.97% 68.5% 69.64%
% of Gross Profit
Research & Development $14.04M $14.72M $14.09M
YoY Change -17.34% 4.49% 98.14%
% of Gross Profit
Depreciation & Amortization $90.00K $80.00K $80.00K
YoY Change 0.0% 0.0% 166.67%
% of Gross Profit
Operating Expenses $21.68M $21.78M $18.27M
YoY Change -1.07% 19.22% 90.82%
Operating Profit -$21.68M -$21.78M -$18.27M
YoY Change -1.07% 19.22% 90.82%
Interest Expense $130.0K $160.0K $660.0K
YoY Change -68.29% -75.76% 29.41%
% of Operating Profit
Other Income/Expense, Net -$157.0K -$131.0K $0.00
YoY Change
Pretax Income -$21.71M -$21.75M -$17.61M
YoY Change 0.93% 23.51% 94.37%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$21.71M -$21.75M -$17.61M
YoY Change 0.93% 23.52% 94.35%
Net Earnings / Revenue
Basic Earnings Per Share -$0.73
Diluted Earnings Per Share -$0.73 -$0.74 -$0.60
COMMON SHARES
Basic Shares Outstanding 29.69M 29.59M
Diluted Shares Outstanding 29.77M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.4M $130.0M $144.5M
YoY Change -16.97% -10.07% 12.64%
Cash & Equivalents $62.21M $74.05M $66.16M
Short-Term Investments $52.21M $55.90M $78.30M
Other Short-Term Assets $495.0K $438.0K $883.0K
YoY Change -21.3% -50.4% 97.98%
Inventory
Prepaid Expenses $472.0K $459.0K $142.0K
Receivables
Other Receivables
Total Short-Term Assets $119.4M $135.8M $151.6M
YoY Change -16.47% -10.39% 13.44%
LONG-TERM ASSETS
Property, Plant & Equipment $303.0K $390.0K $1.300M
YoY Change -39.4% -70.0% 390.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $26.10M $23.50M $66.10M
YoY Change -56.57% -64.45% 726.25%
Other Assets $193.0K $145.0K $200.0K
YoY Change -7.66% -27.5% -23.08%
Total Long-Term Assets $27.99M $25.55M $67.60M
YoY Change -54.63% -62.21% 604.24%
TOTAL ASSETS
Total Short-Term Assets $119.4M $135.8M $151.6M
Total Long-Term Assets $27.99M $25.55M $67.60M
Total Assets $147.4M $161.4M $219.2M
YoY Change -27.97% -26.37% 53.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.880M $7.193M $5.100M
YoY Change -33.16% 41.04% -0.31%
Accrued Expenses $11.27M $11.34M $8.600M
YoY Change -6.83% 31.91% 350.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.15M $18.54M $13.70M
YoY Change -13.74% 35.31% 95.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $600.0K $800.0K $100.0K
YoY Change 200.0% 700.0%
Total Long-Term Liabilities $600.0K $800.0K $100.0K
YoY Change 200.0% 700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.15M $18.54M $13.70M
Total Long-Term Liabilities $600.0K $800.0K $100.0K
Total Liabilities $14.76M $19.31M $13.70M
YoY Change -11.59% 40.95% 95.02%
SHAREHOLDERS EQUITY
Retained Earnings -$213.2M -$191.5M
YoY Change 69.07%
Common Stock $345.8M $333.5M
YoY Change 10.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $132.7M $142.1M $205.5M
YoY Change
Total Liabilities & Shareholders Equity $147.4M $161.4M $219.2M
YoY Change -27.97% -26.37% 53.03%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$21.71M -$21.75M -$17.61M
YoY Change 0.93% 23.52% 94.35%
Depreciation, Depletion And Amortization $90.00K $80.00K $80.00K
YoY Change 0.0% 0.0% 166.67%
Cash From Operating Activities -$17.34M -$17.56M -$14.39M
YoY Change 40.18% 22.03% 128.05%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $100.0K $10.00K
YoY Change -100.0% 900.0% -133.33%
Acquisitions
YoY Change
Other Investing Activities $770.0K $5.720M -$5.930M
YoY Change -92.59% -196.46% -87.61%
Cash From Investing Activities $760.0K $5.630M -$5.950M
YoY Change -92.67% -194.62% -87.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.710M 670.0K 890.0K
YoY Change 5133.33% -24.72% -98.86%
NET CHANGE
Cash From Operating Activities -17.34M -17.56M -14.39M
Cash From Investing Activities 760.0K 5.630M -5.950M
Cash From Financing Activities 4.710M 670.0K 890.0K
Net Change In Cash -11.87M -11.26M -19.45M
YoY Change 521.47% -42.11% -182.07%
FREE CASH FLOW
Cash From Operating Activities -$17.34M -$17.56M -$14.39M
Capital Expenditures $0.00 $100.0K $10.00K
Free Cash Flow -$17.34M -$17.66M -$14.40M
YoY Change 39.95% 22.64% 129.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001662774
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2019Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 crtx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
crtx Entity Date Of Incorporation
EntityDateOfIncorporation
2012-06
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1024039
dei Entity Address Address Line1
EntityAddressAddressLine1
269 East Grand Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38890
dei Entity Registrant Name
EntityRegistrantName
Cortexyme, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Local Phone Number
LocalPhoneNumber
910-5717
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
415
dei Trading Symbol
TradingSymbol
CRTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29685786
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74049000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
55901000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5893000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4042000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
135843000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
137862000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
390000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1496000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
674000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
23516000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
145000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39000
CY2021Q2 us-gaap Assets
Assets
161390000
CY2020Q4 us-gaap Assets
Assets
189466000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7193000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3555000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11344000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13441000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
18537000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16996000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
773000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
208000
CY2021Q2 us-gaap Liabilities
Liabilities
19310000
CY2020Q4 us-gaap Liabilities
Liabilities
17204000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29655786
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29655786
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29543222
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29543222
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
30000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
29000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
333427000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
318574000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
117000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
313000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191494000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146654000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
142080000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
172262000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
161390000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189466000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14719000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14086000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31543000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28467000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7064000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4185000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13553000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7662000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
21783000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
18271000
us-gaap Operating Expenses
OperatingExpenses
45096000
us-gaap Operating Expenses
OperatingExpenses
36129000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21783000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18271000
us-gaap Operating Income Loss
OperatingIncomeLoss
-45096000
us-gaap Operating Income Loss
OperatingIncomeLoss
-36129000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
160000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
659000
us-gaap Investment Income Interest
InvestmentIncomeInterest
387000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1341000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21754000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17612000
us-gaap Net Income Loss
NetIncomeLoss
-44840000
us-gaap Net Income Loss
NetIncomeLoss
-34788000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-72000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
748000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-196000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
651000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21826000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16864000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45036000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34137000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29587352
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29442915
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29571226
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28852317
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
156484000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
672000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6750000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-72000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21754000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
142080000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
218041000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-62000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
954000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3398000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
748000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-17612000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
205467000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
172262000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1113000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13741000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-196000
us-gaap Net Income Loss
NetIncomeLoss
-44840000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
142080000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
115478000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
117628000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1145000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5353000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
651000
us-gaap Net Income Loss
NetIncomeLoss
-34788000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
205467000
us-gaap Profit Loss
ProfitLoss
-44840000
us-gaap Profit Loss
ProfitLoss
-34788000
crtx Non Cash Rent Expense
NonCashRentExpense
188000
crtx Non Cash Rent Expense
NonCashRentExpense
184000
us-gaap Share Based Compensation
ShareBasedCompensation
13741000
us-gaap Share Based Compensation
ShareBasedCompensation
5353000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
173000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
163000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-442000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-228000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1851000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
880000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
106000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
27000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3638000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2016000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2557000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2580000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31172000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25171000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25165000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
139407000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
62568000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
60801000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37267000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78628000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1113000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1145000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
117628000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1113000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118741000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7208000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14942000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51214000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74049000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66156000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1210000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
293000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191500000
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
130000000.0
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
23500000
CY2021Q2 crtx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
8368000
CY2020Q4 crtx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
10603000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:43.2pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses, as well as related disclosure of contingent assets and liabilities. The most significant estimates used in the Company’s consolidated financial statements relate to the stock-based awards and other issuances, accruals for research and development costs, useful lives of long-lived assets, stock-based compensation and related assumptions, the incremental borrowing rate for leases and income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from the Company’s estimates.</span></p>
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
147722000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148594000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
147605000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
141000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
147722000
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
68305000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
55901000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
23516000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
147722000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
148281000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
368000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
55000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
148594000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31151000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
148594000
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2021Q2 crtx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
crtx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74049000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
55901000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66979000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
23516000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
50464000
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
459000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274000
CY2021Q2 crtx Prepaid Insurance Current
PrepaidInsuranceCurrent
2775000
CY2020Q4 crtx Prepaid Insurance Current
PrepaidInsuranceCurrent
964000
CY2021Q2 crtx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
2221000
CY2020Q4 crtx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
2110000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
438000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
694000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5893000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4042000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
788000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
615000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
390000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2082000
CY2020Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2415000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
172000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
141000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
722000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
282000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11344000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13441000
CY2018Q2 crtx Number Of Investors
NumberOfInvestors
1
CY2018Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2018Q2 crtx Repurchase Option Percentage
RepurchaseOptionPercentage
1
CY2018Q2 crtx Operating Leases Period
OperatingLeasesPeriod
P3Y
CY2019Q2 crtx Operating Lease Payments Paid For Additional Space
OperatingLeasePaymentsPaidForAdditionalSpace
63000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2020Q2 crtx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
172000
crtx Payments For Security Deposit
PaymentsForSecurityDeposit
105000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000
crtx Operating Lease Future Rent Expense
OperatingLeaseFutureRentExpense
1435000
crtx Finance Lease Right Of Use Asset Depreciation Expense
FinanceLeaseRightOfUseAssetDepreciationExpense
113000
crtx Finance Lease Right Of Use Asset Depreciation Expense
FinanceLeaseRightOfUseAssetDepreciationExpense
117000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1496000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
674000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
699000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
238000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
773000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
208000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1472000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
446000
CY2021Q2 crtx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
557000
CY2020Q4 crtx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
557000
CY2021Q2 crtx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
450000
CY2020Q4 crtx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
337000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
107000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
220000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0188
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0210
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
359000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
733000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
410000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1502000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
30000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1472000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
71500000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7D
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6750000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3398000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13741000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5353000
crtx Provision For Income Taxes
ProvisionForIncomeTaxes
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5653919000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3644772000

Files In Submission

Name View Source Status
0000950170-21-001015-index-headers.html Edgar Link pending
0000950170-21-001015-index.html Edgar Link pending
0000950170-21-001015.txt Edgar Link pending
0000950170-21-001015-xbrl.zip Edgar Link pending
crtx-20210630.htm Edgar Link pending
crtx-20210630.xsd Edgar Link pending
crtx-20210630ex10_1.htm Edgar Link pending
crtx-20210630ex10_2.htm Edgar Link pending
crtx-20210630ex10_3.htm Edgar Link pending
crtx-20210630ex10_4.htm Edgar Link pending
crtx-20210630ex10_5.htm Edgar Link pending
crtx-20210630ex10_6.htm Edgar Link pending
crtx-20210630ex10_7.htm Edgar Link pending
crtx-20210630ex31_1.htm Edgar Link pending
crtx-20210630ex31_2.htm Edgar Link pending
crtx-20210630ex32_1.htm Edgar Link pending
crtx-20210630ex32_2.htm Edgar Link pending
crtx-20210630_cal.xml Edgar Link unprocessable
crtx-20210630_def.xml Edgar Link unprocessable
crtx-20210630_htm.xml Edgar Link completed
crtx-20210630_lab.xml Edgar Link unprocessable
crtx-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending